financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Buy Opinion On Shares Of Zions Bancorporation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Buy Opinion On Shares Of Zions Bancorporation
Oct 21, 2025 11:52 AM

02:15 PM EDT, 10/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We increase our 12-month target price by $11 to $65, 10.8x our 2026 EPS estimate, a premium to the peer average of 9.9x given solid balance sheet growth prospects. We increase our 2025 EPS estimate by $0.53 to $5.91 and 2026's by $0.39 to $6.03. We were encouraged by ZION's transparency this quarter as management fielded questions for 55 minutes while directly addressing key credit concerns. Importantly, ZION confirmed it has no additional exposure to Cantor Group and expressed confidence that the recent fraud incident was isolated. Leading indicators are encouraging, with nonperforming assets remaining steady while criticized and classified balances improved. For investors concerned about banks with loan exposure to non-depository financial institutions (NDFIs), ZION actually screens exceptionally well with just 3% of loans in this category versus 5%-20% for most other banks. Beyond credit quality, core operating metrics show encouraging trends, with both net interest margin and efficiency ratios improving.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Buy Opinion On Shares Of Kkr & Co. Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Kkr & Co. Inc.
Sep 10, 2025
01:45 PM EDT, 09/10/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price by $11 to $165 using a forward P/E 24.6x our 2026 earnings estimate, just below the five-year historical average at 26.9x and near direct peers....
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Sep 11, 2025
02:50 AM EDT, 09/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our target price of USD61, implying 16.3x our 2025 EPADS, a discount to historical forward P/E of 25x-30x to reflect growing concerns about long-term competitive positioning, yet above...
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Chewy, Inc.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Chewy, Inc.
Sep 10, 2025
01:50 AM EDT, 09/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target by $1 to $54, based on a blended valuation of 20x FY 27 (Jan.) EBITDA and 2.0x FY 27 EV/sales. We lift our FY 26...
Research Alert: CFRA Lowers Opinion On Shares Of Fedex Corporation To Sell From Hold
Research Alert: CFRA Lowers Opinion On Shares Of Fedex Corporation To Sell From Hold
Sep 11, 2025
03:00 PM EDT, 09/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target price by $7 to $219, 12.1x our FY 26 (May) EPS view and below FDX's three- and five-year forward average of 12.8x. We cut our...
Copyright 2023-2026 - www.financetom.com All Rights Reserved